These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 20826009)

  • 21. Status of donor-recipient HLA class I ligands and not the KIR genotype is predictive for the outcome of unrelated hematopoietic stem cell transplantation in beta-thalassemia patients.
    La Nasa G; Littera R; Locatelli F; Giardini C; Ventrella A; Mulargia M; Vacca A; Orrù N; Orrù S; Piras E; Giustolisi G; Lisini D; Nesci S; Caocci G; Carcassi C
    Biol Blood Marrow Transplant; 2007 Nov; 13(11):1358-68. PubMed ID: 17950922
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiple sclerosis associates with LILRA3 deletion in Spanish patients.
    Ordóñez D; Sánchez AJ; Martínez-Rodríguez JE; Cisneros E; Ramil E; Romo N; Moraru M; Munteis E; López-Botet M; Roquer J; García-Merino A; Vilches C
    Genes Immun; 2009 Sep; 10(6):579-85. PubMed ID: 19421224
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Distribution of Killer cell immunoglobulin like receptor genes in end stage renal disease among North Indian population.
    Prakash S; Alam S; Sharma RK; Sonawane A; Imran M; Agrawal S
    Hum Immunol; 2013 Oct; 74(10):1339-45. PubMed ID: 23777934
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Study of KIR expression and HLA ligands in CD56+ lymphocytes of drug resistant tuberculosis patients.
    Mousavi T; Shahsavar F; Farnia P; Tajik N; Soofi M
    Iran J Allergy Asthma Immunol; 2011 Sep; 10(3):189-94. PubMed ID: 21891825
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Autologous and allogeneic HLA KIR ligand environments and activating KIR control KIR NK-cell functions.
    Morvan M; David G; Sébille V; Perrin A; Gagne K; Willem C; Kerdudou N; Denis L; Clémenceau B; Folléa G; Bignon JD; Retière C
    Eur J Immunol; 2008 Dec; 38(12):3474-86. PubMed ID: 19016529
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of Killer Cell Immunoglobulin-Like Receptor Genes and Their HLA Ligands in Inflammatory Bowel Diseases.
    Beigmohammadi F; Mahmoudi M; Karami J; Ahmadzadeh N; Ebrahimi-Daryani N; Rezaei N
    J Immunol Res; 2020; 2020():4873648. PubMed ID: 33015197
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognosis after unmanipulated HLA-haploidentical blood and marrow transplantation is correlated to the numbers of KIR ligands in recipients.
    Zhao XY; Huang XJ; Liu KY; Xu LP; Liu DH
    Eur J Haematol; 2007 Apr; 78(4):338-46. PubMed ID: 17378893
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Killer cell immunoglobulin-like receptors influence the innate and adaptive immune responses.
    Rajalingam R
    Iran J Immunol; 2007 Jun; 4(2):61-78. PubMed ID: 17652846
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of Killer Cell Immunoglobulin-like Receptor Genes and Their HLA Ligands in Iranian Patients with Ankylosing Spondylitis.
    Mahmoudi M; Jamshidi AR; Karami J; Mohseni A; Amirzargar AA; Farhadi E; Ahmadzadeh N; Nicknam MH
    Iran J Allergy Asthma Immunol; 2016 Feb; 15(1):27-38. PubMed ID: 26996109
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activating killer immunoglobulin-like receptor incompatibilities enhance graft-versus-host disease and affect survival after allogeneic hematopoietic stem cell transplantation.
    Giebel S; Nowak I; Dziaczkowska J; Czerw T; Wojnar J; Krawczyk-Kulis M; Holowiecki J; Holowiecka-Goral A; Markiewicz M; Kopera M; Karolczyk A; Kyrcz-Krzemien S; Kusnierczyk P
    Eur J Haematol; 2009 Oct; 83(4):343-56. PubMed ID: 19500138
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of KIR genes and their HLA ligands in susceptibility to dengue in a population from southern Brazil.
    Beltrame LM; Sell AM; Moliterno RA; Clementino SL; Cardozo DM; Dalalio MM; Fonzar UJ; Visentainer JE
    Tissue Antigens; 2013 Dec; 82(6):397-404. PubMed ID: 24498996
    [TBL] [Abstract][Full Text] [Related]  

  • 32. KIR/HLA ligand incompatibility in kidney transplantation.
    Kunert K; Seiler M; Mashreghi MF; Klippert K; Schönemann C; Neumann K; Pratschke J; Reinke P; Volk HD; Kotsch K
    Transplantation; 2007 Dec; 84(11):1527-33. PubMed ID: 18091530
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disparate distribution of activating and inhibitory killer cell immunoglobulin-like receptor genes in patients with systemic lupus erythematosus.
    Hou YF; Zhang YC; Jiao YL; Wang LC; Li JF; Pan ZL; Yang QR; Sun HS; Zhao YR
    Lupus; 2010 Jan; 19(1):20-6. PubMed ID: 19926642
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modelling KIR-HLA genotype disparities in type 1 diabetes.
    van der Slik AR; Alizadeh BZ; Koeleman BP; Roep BO; Giphart MJ
    Tissue Antigens; 2007 Apr; 69 Suppl 1():101-5. PubMed ID: 17445178
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A study of the killer cell immunoglobulin-like receptor gene KIR2DS1 in a Caucasoid Brazilian population with psoriasis vulgaris.
    Jobim M; Jobim LF; Salim PH; Cestari TF; Toresan R; Gil BC; Jobim MR; Wilson TJ; Kruger M; Schlottfeldt J; Schwartsmann G
    Tissue Antigens; 2008 Oct; 72(4):392-6. PubMed ID: 18643961
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oligoclonal band phenotypes in MS differ in their HLA class II association, while specific KIR ligands at HLA class I show association to MS in general.
    Gustavsen MW; Viken MK; Celius EG; Berge T; Mero IL; Berg-Hansen P; Aarseth JH; Myhr KM; Søndergaard HB; Sellebjerg F; Oturai AB; Hillert J; Alfredsson L; Olsson T; Kockum I; Lie BA; Harbo HF
    J Neuroimmunol; 2014 Sep; 274(1-2):174-9. PubMed ID: 25037176
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of the HLA-C2-specific activating killer-cell Ig-like receptor KIR2DS1 on NK and T cells.
    Cognet C; Farnarier C; Gauthier L; Frassati C; André P; Magérus-Chatinet A; Anfossi N; Rieux-Laucat F; Vivier E; Schleinitz N
    Clin Immunol; 2010 Apr; 135(1):26-32. PubMed ID: 20093094
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Natural killer receptors distribution in multiple sclerosis: Relation to clinical course and interferon-beta therapy.
    Martínez-Rodríguez JE; Saez-Borderías A; Munteis E; Romo N; Roquer J; López-Botet M
    Clin Immunol; 2010 Oct; 137(1):41-50. PubMed ID: 20580616
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potential implication of activating killer cell immunoglobulin-like receptor and HLA in onset of pulmonary tuberculosis.
    Lu C; Bai XL; Shen YJ; Deng YF; Wang CY; Fan G; Chu JX; Zhao SM; Zhang BC; Zhao YR; Zhang CZ; Ye H; Lu ZM
    Scand J Immunol; 2012 Nov; 76(5):491-6. PubMed ID: 22862677
    [TBL] [Abstract][Full Text] [Related]  

  • 40. No association of KIR genes with Behcet's disease.
    Middleton D; Meenagh A; Sleator C; Gourraud PA; Ayna T; Tozkir H; Köse AA; Azizleri G; Diler AS
    Tissue Antigens; 2007 Nov; 70(5):435-8. PubMed ID: 17868255
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.